Nakamae H, Storer B, Sandmaier BM, Maloney DG, Davis C, Corey L, Storb R, Boeckh M: Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica. 2011, 96 (12): 1838-1845. 10.3324/haematol.2011.044966.
Article
PubMed
PubMed Central
Google Scholar
Thoma MD, Huneke TJ, DeCook LJ, Johnson ND, Wiegand RA, Litzow MR, Hogan WJ, Porrata LF, Holtan SG: Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2012, 18 (4): 600-607. 10.1016/j.bbmt.2011.08.007.
Article
PubMed
Google Scholar
DeCook LJ, Thoma M, Huneke T, Johnson ND, Wiegand RA, Patnaik MM, Litzow MR, Hogan WJ, Porrata LF, Holtan SG: Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning. Bone Marrow Transplant. 2013, 48 (5): 708-714. 10.1038/bmt.2012.211.
Article
CAS
PubMed
Google Scholar
Mielcarek M, Martin PJ, Torok-Storb B: Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 1997, 89 (5): 1629-1634.
CAS
PubMed
Google Scholar
Aranha FJ, Vigorito AC, De Sousa CA, Oliveira GB, Zulli R, Lorand-Metze I: The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation. Haematologica. 2002, 87 (2): 219-220.
PubMed
Google Scholar
Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ: The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. Biol Blood Marrow Transplant. 2010, 16 (2): 253-262. 10.1016/j.bbmt.2009.10.004.
Article
PubMed
Google Scholar
Cox CJ, Habermann TM, Payne BA, Klee GG, Pierre RV: Evaluation of the Coulter Counter model S-Plus IV. Am J Clin Pathol. 1985, 84 (3): 297-306.
Article
CAS
PubMed
Google Scholar
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974, 18 (4): 295-304. 10.1097/00007890-197410000-00001.
Article
CAS
PubMed
Google Scholar
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Biol Blood Marrow Transplant. 2005, 11 (12): 945-956. 10.1016/j.bbmt.2005.09.004.
Article
PubMed
Google Scholar
Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481. 10.1080/01621459.1958.10501452.
Article
Google Scholar
Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN: The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia. 2004, 18 (6): 1085-1092. 10.1038/sj.leu.2403341.
Article
CAS
PubMed
Google Scholar
Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Ansell SM, Micallef IN, Markovic SN: Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin’s lymphoma. Bone Marrow Transplant. 2004, 33 (3): 291-298. 10.1038/sj.bmt.1704355.
Article
CAS
PubMed
Google Scholar
Porrata LF, Gastineau DA, Padley D, Bundy K, Markovic SN: Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leuk Lymphoma. 2003, 44 (6): 997-1000. 10.1080/1042819031000077089.
Article
CAS
PubMed
Google Scholar
Porrata LF, Inwards DJ, Ansell SA, Micallef IN, Johnston PB, Hogan WJ, Markovic SN: Day 15 Peripheral Blood Lymphocyte/monocyte Ratio Post-Autologous Peripheral Hematopoietic Stem Cell Transplantation and Survival in Diffuse Large B-cell Lymphoma. J Stem Cell Res Ther. 2011, 1: 103-
Article
Google Scholar
Bolanos-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L: Lymphocyte Phenotype during Therapy for Acute Graft-versus-Host Disease: A Brief Report from BMT-CTN 0302. Biol Blood Marrow Transplant. 19 (3): 481-485.
Nakamura R, Auayporn N, Smith DD, Palmer J, Sun JY, Schriber J, Pullarkat V, Parker P, Rodriguez R, Stein A, Rosenthal J, Wang S, Karanas C, Gaal K, Senitzer D, Forman SJ: Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant. 2008, 14 (4): 449-457. 10.1016/j.bbmt.2008.02.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim DH, Won DI, Lee NY, Sohn SK, Suh JS, Lee KB: Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Biol Blood Marrow Transplant. 2006, 12 (7): 719-728. 10.1016/j.bbmt.2006.03.005.
Article
CAS
PubMed
Google Scholar
Vela-Ojeda J, Garcia-Ruiz Esparza MA, Reyes-Maldonado E, Jimenez-Zamudio L, Garcia-Latorre E, Moreno-Lafont M, Estrada-Garcia I, Montiel-Cervantes L, Tripp-Villanueva F, Ayala-Sanchez M, Garcia-Leon LD, Borbolla-Escoboza JR, Mayani H: Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Ann Hematol. 2006, 85 (2): 113-120. 10.1007/s00277-005-0037-5.
Article
CAS
PubMed
Google Scholar
Cao TM, Shizuru JA, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Stuart MJ, Grumet FC, Negrin RS, Lowsky R: Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood. 2005, 105 (6): 2300-2306. 10.1182/blood-2004-04-1473.
Article
CAS
PubMed
Google Scholar
Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK: Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biol Blood Marrow Transplant. 2013, 19 (3): 460-467. 10.1016/j.bbmt.2012.11.017.
Article
CAS
PubMed
Google Scholar
Holtan SG, Pasquini M, Weisdorf DJ: Acute graft-versus-host disease: a bench-to-bedside update. Blood. 2014, 124 (3): 363-373. 10.1182/blood-2014-01-514786.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maciejewski J, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995, 85 (11): 3183-3190.
CAS
PubMed
Google Scholar
Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE: Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood. 2001, 98 (6): 1782-1791. 10.1182/blood.V98.6.1782.
Article
CAS
PubMed
Google Scholar
Dubey S, Shukla P, Nityanand S: Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol. 2005, 84 (9): 572-577. 10.1007/s00277-005-1022-8.
Article
CAS
PubMed
Google Scholar
Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE: IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005, 174 (2): 752-757. 10.4049/jimmunol.174.2.752.
Article
CAS
PubMed
Google Scholar
Pronk CJ, Veiby OP, Bryder D, Jacobsen SE: Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J Exp Med. 2011, 208 (8): 1563-1570. 10.1084/jem.20110752.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM: Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999, 94 (11): 3941-3946.
CAS
PubMed
Google Scholar
Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T, Schwarer A, Szer J, Tait B, To B, Bardy P: Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 2004, 77 (4): 587-596. 10.1097/01.TP.0000111769.45088.A2.
Article
CAS
PubMed
Google Scholar
Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S, Marsh SG: Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol. 2007, 25 (27): 4262-4269. 10.1200/JCO.2007.12.1897.
Article
CAS
PubMed
Google Scholar
Newell LF, Gooley T, Hansen JA, Stirewalt DL, Petersdorf EW, Deeg HJ: Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15. Biol Blood Marrow Transplant. 2010, 16 (12): 1700-1706. 10.1016/j.bbmt.2010.06.003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T: MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation. Sci Transl Med. 2012, 4 (144): 144ra101-
Article
PubMed
PubMed Central
Google Scholar
Melenhorst JJ, Tian X, Xu D, Sandler NG, Scheinberg P, Biancotto A, Scheinberg P, McCoy JP, Hensel NF, McIver Z, Douek DC, Barrett AJ: Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation. Haematologica. 2012, 97 (6): 867-873. 10.3324/haematol.2011.053363.
Article
CAS
PubMed
PubMed Central
Google Scholar
Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L, Superata J, Kurlander R, Singh A, Childs R, Barrett AJ: Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007, 13 (10): 1216-1223. 10.1016/j.bbmt.2007.07.005.
Article
PubMed
PubMed Central
Google Scholar
Burke MJ, Vogel RI, Janardan SK, Brunstein C, Smith AR, Miller JS, Weisdorf D, Wagner JE, Verneris MR: Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. Biol Blood Marrow Transplant. 2011, 17 (6): 831-840. 10.1016/j.bbmt.2010.08.022.
Article
PubMed
Google Scholar
Chang YJ, Zhao XY, Xu LP, Liu DH, Liu KY, Chen YH, Wang Y, Zhang XH, Zhao XS, Han W, Chen H, Wang FR, Lv M, Huang XJ: Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome. Leuk Lymphoma. 2013, 54 (12): 2671-2677. 10.3109/10428194.2013.783912.
Article
PubMed
Google Scholar
Delia M, Pastore D, Mestice A, Carluccio P, Perrone T, Gaudio F, Ricco A, Sgherza N, Albano F, Specchia G: Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. Biol Blood Marrow Transplant. 2013, 19 (3): 495-499. 10.1016/j.bbmt.2012.11.015.
Article
PubMed
Google Scholar
Khera N, Zeliadt SB, Lee SJ: Economics of hematopoietic cell transplantation. Blood. 120 (8): 1545-1551.
Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE: High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. Clin Transpl. 2013, 27 (1): E56-63. 10.1111/ctr.12065.
Article
Google Scholar